The number of Americans without healthcare insurance rose by 3.2 million people between 2016 and 2017 – or 1.3 percentage points to 12.2 percent – according to a Gallup poll, the biggest jump in the uninsured rate in nearly a decade.

Eighteen U.S. states sued President Donald Trump’s administration to stop him from scrapping a key component of Obamacare, subsidies to insurers that help millions of low-income people pay medical expenses, even as Trump invited Democratic leaders to negotiate a deal.

While the nation’s media was focusing on the unsuccessful attempts by Republicans to pass a successor to Obamacare, a fascinating sideshow has developed in nearby White Oak, Maryland, home of the Food and Drug Administration.

President Donald Trump and Republicans in Congress said they will unveil plans to repeal and replace Obamacare, providing a timeframe for a legislative goal they have struggled with for weeks.

As a public official preparing for international negotiations, I was taught by the U.S. State Department to always know exactly what you want and what you’re willing to give up before sitting down with a skilled international trading partner. It looks like pharma representatives were well prepared recently when sitting down with the country’s new Negotiator-in-Chief, President Donald Trump, but they should be mindful that the other shoe has yet to drop.

Democrats are showing little interest in cooperating with the Republicans who control Congress on legislation to dismantle the Obamacare health insurance law, but some are signaling a willingness to collaborate on action to curb rising drug prices.

The reality of a President-elect Donald Trump has been a shot in the arm for pharma and biotech leaders’ stock prices as they surged in U.S. and European markets.

U.S. Vice President Joseph Biden’s Cancer Moonshot initiative to speed the development of cancer treatments has made some important strides, but still faces challenges in many areas according to a report.

Researchers revealed the first U.S. case of a pathogen carrying a mutated strain of E. coli resistant to an antibiotic used as a final defense versus superbugs. As a result, there has been heightened concern that a post-antibiotic era will arrive earlier than predicted.

A bipartisan group of senators will soon offer a proposal for more funding to fight a Zika outbreak spreading rapidly through the Americas, Senate Appropriations Committee Chairman Thad Cochran said on Thursday.   Democrats and Obama administration officials have urged the Republican-controlled Congress to grant nearly $1.9 billion in emergency funds to combat Zika, a […]